Lunesta News
Sepracor gets FDA nod for asthma drug
The U.S. Food and Drug Administration approved the Marlborough company's new drug application for an inhaler version of the drug.
For full story, click here
Information provided on this site is for educational purposes only. Lunesta is a registered trademark of Sepracor Inc. This site is not endorsed or affiliated with Sepracor Inc. in any way.
